Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 16/20 | 0.57 |
| ▸ | ITGAV | P06756 | 15/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.56 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7099298 | 0.92 | ITGB3 (0.66) | ITGB3ITGAVITGA2BHTTSMN1; SMN2 | |
| SCHEMBL7105309 | 0.90 | ITGB3 (0.68) | ITGB3ITGAVITGA2BFNTAFNTB | |
| SCHEMBL7099697 | 0.90 | ITGB3 (0.68) | ITGB3ITGAVITGA2BFNTAFNTB | |
| SCHEMBL7104742 | 0.90 | ITGB3 (0.68) | ITGB3ITGAVITGA2BPARP1 | |
| SCHEMBL7102231 | 0.90 | ITGB3 (0.68) | ITGB3ITGAVITGA2BFNTAFNTB | |
| SCHEMBL7105191 | 0.89 | ITGB3 (0.69) | ITGB3ITGAVITGA2BFNTAFNTB | |
| SCHEMBL7103664 | 0.86 | ITGB3 (0.68) | ITGB3ITGAVITGA2B | |
| SCHEMBL7098481 | 0.82 | ITGB3 (0.67) | ITGB3ITGAVITGA2BHTTSMN1; SMN2 | |
| SCHEMBL7106602 | 0.82 | ITGB3 (0.67) | ITGB3ITGAVITGA2BFNTAFNTB | |
| SCHEMBL7098907 | 0.82 | ITGB3 (0.67) | ITGB3ITGAVITGA2BFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090232741-A1 | Optical Imaging | GE HEALTHCARE AS (NO) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090232741-A1 | Optical Imaging | AGER, KDR, FLT4 | ITGB3 78/4885ITGAV 49/4885ITGA2B 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.